HeartFlow was last valued at $1.6B. It dates from Aug 2025. HeartFlow is a public company.
One company valuation: $1.6B, dated Aug 2025.
Lead investors for each round are in the funding timeline.
The closest medical ai / cardiac diagnostics peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
Yes. HeartFlow is listed on NASDAQ as HFLO.
The last valuation is $1.6B.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
